444 filings
425
AKTX
Akari Therapeutics Plc
1 May 24
Business combination disclosure
5:27pm
8-K
AKTX
Akari Therapeutics Plc
1 May 24
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
5:04pm
8-K
AKTX
Akari Therapeutics Plc
11 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:30am
8-K
AKTX
Akari Therapeutics Plc
1 Apr 24
Akari Therapeutics Reports Full-Year
6:30am
10-K
2023 FY
AKTX
Akari Therapeutics Plc
Annual report
29 Mar 24
4:15pm
425
scx54
11 Mar 24
Business combination disclosure
5:25pm
8-K
0nw sopabr3
11 Mar 24
Entry into a Material Definitive Agreement
5:24pm
425
uxuak xj9
5 Mar 24
Business combination disclosure
4:57pm
425
3qu012v
5 Mar 24
Business combination disclosure
8:34am
8-K
2dal3vxocg
5 Mar 24
Entry into a Material Definitive Agreement
8:28am
D
bjzstc6 ndv1v9wx
9 Jan 24
$2.00 mm in equity / securities to be acquired, sold $2.00 mm, 2 investors
5:25pm
8-K
8dqtqh
2 Jan 24
Akari Therapeutics Announces Existing Investors Support the Company
4:30pm
6-K
s2nhrhsjv96 icqsf
1 Dec 23
Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors
8:00am
6-K
9kw 85677i23li8v3qb3
16 Nov 23
Current report (foreign)
8:00am
424B3
ltq2fq
27 Oct 23
Prospectus supplement
4:15pm
EFFECT
2fyaj8o57ek93act3840
27 Oct 23
Notice of effectiveness
12:15am
CORRESP
gdssp
25 Oct 23
Correspondence with SEC
12:00am
EFFECT
oksfsd34244zp4
24 Oct 23
Notice of effectiveness
12:15am
EFFECT
hdmc5lle6zl
24 Oct 23
Notice of effectiveness
12:15am
UPLOAD
bid7jt11k6 n2ybmfm6h
24 Oct 23
Letter from SEC
12:00am